“What’s Next in Biotech” In Conversation with Venrock Partner Bryan Roberts

Join us for an Exclusive Premiere on What’s Next in Biotech with Gunderson Partner and Chair of Life Sciences Tim Ehrlich and Venrock Partner Bryan Roberts. This session features deep dives and candid answers to sector-defining questions, including: ·

• • What are the biggest shifts in fundraising and investment strategies seen in recent years?
  • How do downturns and decelerations in biotech now compare with the past?
  • What triggers could unlock fresh capital for private biotechs?
  • Which startups, therapeutic areas, and partnerships are attracting major investor attention in 2025?
  • Is the current climate accelerating innovations in areas like AI and cross-border clinical trials?

What’s Next in Biotech, developed by Gunderson Dettmer Partner Tim Ehrlich, features true leaders in the life sciences industry, creating conversation and relevant insights to how the market is evolving and responding to market condition by the leaders who build and support the new generation of life sciences and biotech companies.